ClinicalTrials.Veeva

Menu

Prophylactic Photodynamic Therapy to Organ Transplant Patients

B

Bispebjerg Hospital

Status

Unknown

Conditions

Organ Transplants

Treatments

Procedure: Photodynamic Therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT00365521
KF-01-314759

Details and patient eligibility

About

To evaluate a possible prophylactic efficacy of photodynamic therapy on the incidence of non-melanoma skin cancer, actinic keratoses, warts and keratoses in recently organ transplanted recipients.

Enrollment

50 estimated patients

Sex

All

Ages

40 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Organ transplant recipients.
  • Age 40 years or older.

Exclusion criteria

  • Patients younger than 40 years and older than 70 years.
  • Clinical signs of skin cancer, actinic keratoses or warts at the time of inclusion.
  • Previous photodynamic therapy to the skin areas investigated.
  • Pregnancy or breast feeding patients.
  • Patients with porphyria.
  • Patients with a tendency to produce hypertrophic scars or keloids.
  • Patients with known allergy to Metvix.
  • Patients who are not considered able to follow the treatment protocol (e.g. severely alcoholic patients, dementia patients, mentally ill patients etc.).

Trial contacts and locations

1

Loading...

Central trial contact

Merete Hædersdal, MD, PhD, DrMedSci

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems